In a hallmark moment for the biotechnology sector, Lycia Therapeutics—a pioneer in the burgeoning field of lysosomal...
Executive Summary: A New Paradigm in Oncology R&D In a move that underscores the shifting landscape of...
NEW YORK, NY — As the world turns its attention to Breast Cancer Awareness Month this October,...
In the landscape of international diplomacy and public health, few institutions carry the weight of the World...
To many, the phrase "breast cancer" is inherently gendered, conjuring images of pink ribbons and women’s health...
In a significant stride for interventional cardiology, Teleflex Incorporated has announced that its Freesolve Resorbable Magnesium Scaffold...
Oklahoma City, OK – In a significant stride toward understanding and combating one of the most aggressive...
A groundbreaking clinical trial, HBT-002, has been initiated by US-based biotechnology company HealthBio to investigate a novel...
By Douglas Feil, NBCF Chief Program Officer In recent years, Glucagon-Like Peptide-1 (GLP-1) receptor agonists have surged...
NEW YORK, NY — As the world enters the midpoint of Breast Cancer Awareness Month, a global...
